share_log

Unveiling 4 Analyst Insights On Theravance Biopharma

テラバンスバイオファーマに関する4つのアナリストの洞察を紹介します

Benzinga ·  09/16 08:00

Across the recent three months, 4 analysts have shared their insights on Theravance Biopharma (NASDAQ:TBPH), expressing a variety of opinions spanning from bullish to bearish.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings20200
Last 30D10000
1M Ago00000
2M Ago10200
3M Ago00000

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.25, with a high estimate of $15.00 and a low estimate of $9.00. A 18.33% drop is evident in the current average compared to the previous average price target of $15.00.

1726488035_0.png

Decoding Analyst Ratings: A Detailed Look

A clear picture of Theravance Biopharma's...

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする